Article
Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
24 Jul 2008
Abstract excerpt
BACKGROUND: Strategies to discover circulating protein markers of ovarian cancer are urgently needed. We developed a novel technology that permits us to isolate recombinant antibodies directed against the potential serum biomarkers, to facilitate the further development of affinity reagents necessary to construct diagnostic tests. METHODS: This study presents a novel discovery approach based on serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
